Immunogenicity and Immunomodulatory Properties of Umbilical Cord Lining Mesenchymal Stem Cells

被引:231
作者
Deuse, Tobias [2 ,3 ,7 ]
Stubbendorff, Mandy [2 ]
Tang-Quan, Karis [2 ,3 ]
Phillips, Neil [4 ]
Kay, Mark A. [4 ]
Eiermann, Thomas [5 ]
Phan, Thang T. [6 ]
Volk, Hans-Dieter [8 ]
Reichenspurner, Hermann [2 ,7 ]
Robbins, Robert C. [3 ]
Schrepfer, Sonja [1 ,2 ,3 ,7 ]
机构
[1] Univ Heart Ctr Hamburg, Transplant & Stem Cell Immunobiol Lab, D-20146 Hamburg, Germany
[2] Univ Hosp Hamburg Eppendorf, Cardiovasc Res Ctr, TSI Lab, Hamburg, Germany
[3] Stanford Univ, Sch Med, Standord, CA USA
[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[5] Univ Hosp Hamburg Eppendorf, HLA Lab, Hamburg, Germany
[6] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore
[7] CellResearchCorp, Clin Res Ctr, Singapore, Singapore
[8] Campus Virchow Klinikum, BCRT, Berlin, Germany
关键词
Mesenchymal stem cells (MSCs); Immunogenicity; Immunomodulation; Stem cell transplantation; MARROW STROMAL CELLS; T-LYMPHOCYTE PROLIFERATION; INTERFERON-GAMMA; PROGENITOR CELLS; ADIPOSE-TISSUE; TGF-BETA; INHIBIT; SURVIVAL; THERAPY; HOST;
D O I
10.3727/096368910X536473
中图分类号
Q813 [细胞工程];
学科分类号
摘要
We here present an immunologic head-to-head comparison between human umbilical cord lining mesenchymal stem cells (clMSCs) and adult bone marrow MSCs (bmMSCs) from patients > 65 years of age. clMSCs had significantly lower HLA class I expression, higher production of tolerogenic TGF-beta and IL-10, and showed significantly faster proliferation. In vitro activation of allogeneic lymphocytes and xenogeneic in vivo immune activation was significantly stronger with bmMSCs, whereas immune recognition of clMSCs was significantly weaker. Thus, bmMSCs were more quickly rejected in immunocompetent mice. IFN-gamma at 25 ng/ml increased both immunogenicity by upregulation of HLA class I/ HLA-DR expression and tolerogenicity by increasing intracellular HLA-G and surface HLA-E expression, augmenting TGF-beta and IL-10 release, and inducing indoleamine 2,3-dioxygenase (IDO) expression. Higher concentrations of IFN-gamma (> 50 ng/ml) further enhanced the immunosuppressive phenotype of clMSCs, more strongly downregulating HLA-DR expression and further increasing IDO production (at 500 ng/ml). The net functional immunosuppressive efficacy of MSCs was tested in mixed lymphocyte cultures. Although both clMSCs and bmMSCs significantly reduced in vitro immune activation, clMSCs were significantly more effective than bmMSCs. The veto function of both MSC lines was enhanced in escalating IFN-gamma environments. In conclusion, clMSCs show a more beneficial immunogeneic profile and stronger overall immunosuppressive potential than aged bmMSCs.
引用
收藏
页码:655 / 667
页数:13
相关论文
共 51 条
[31]   Immune modulation by mesenchymal stem cells [J].
Rasmusson, Ida .
EXPERIMENTAL CELL RESEARCH, 2006, 312 (12) :2169-2179
[32]   Embryonic Stem Cell Marker Expression Pattern in Human Mesenchymal Stem Cells Derived from Bone Marrow, Adipose Tissue, Heart and Dermis [J].
Riekstina, Una ;
Cakstina, Inese ;
Parfejevs, Vadims ;
Hoogduijn, Martin ;
Jankovskis, Georgs ;
Muiznieks, Indrikis ;
Muceniece, Ruta ;
Ancans, Janis .
STEM CELL REVIEWS AND REPORTS, 2009, 5 (04) :378-386
[33]   Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease [J].
Ringden, Olle ;
Uzunel, Mehmet ;
Rasmusson, Ida ;
Remberger, Mats ;
Sundberg, Berit ;
Lonnies, Helena ;
Marschall, Hanns-Ulrich ;
Dlugosz, Aldona ;
Szakos, Attila ;
Hassan, Zuzana ;
Omazic, Brigitta ;
Aschan, Johan ;
Barkholt, Lisbeth ;
Le Blanc, Katarina .
TRANSPLANTATION, 2006, 81 (10) :1390-1397
[34]   Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord [J].
Romanov, YA ;
Svintsitskaya, VA ;
Smirnov, VN .
STEM CELLS, 2003, 21 (01) :105-110
[35]   Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-γ, TGF-β, and cell density [J].
Romieu-Mourez, Raphaelle ;
Francois, Moira ;
Boivin, Marie-Noelle ;
Stagg, John ;
Galipeau, Jacques .
JOURNAL OF IMMUNOLOGY, 2007, 179 (03) :1549-1558
[36]   The Mesenchymal Stem Cell Antigen MSCA-1 is Identical to Tissue Non-specific Alkaline Phosphatase [J].
Sobiesiak, Malgorzata ;
Sivasubramaniyan, Kavitha ;
Hermann, Clemens ;
Tan, Charmaine ;
Oergel, Melanie ;
Treml, Sabrina ;
Cerabona, Flavianna ;
de Zwart, Peter ;
Ochs, Uwe ;
Mueller, Claudia A. ;
Gargett, Caroline E. ;
Kalbacher, Hubert ;
Buehring, Hans-Joerg .
STEM CELLS AND DEVELOPMENT, 2010, 19 (05) :669-677
[37]   Interactions between human mesenchymal stem cells and natural killer cells [J].
Sotiropoulou, PA ;
Perez, SA ;
Gritzapis, AD ;
Baxevanis, CN ;
Papamichail, M .
STEM CELLS, 2006, 24 (01) :74-85
[38]   Interferon-γ-stimulated marrow stromal cells:: a new type of nonhematopoietic antigen-presenting cell [J].
Stagg, J ;
Pommey, S ;
Eliopoulos, N ;
Galipeau, J .
BLOOD, 2006, 107 (06) :2570-2577
[39]   HSCT Recipients Have Specific Tolerance to MSC but not to the MSC Donor [J].
Sundin, Mikael ;
Barrett, A. John ;
Ringden, Olle ;
Uzunel, Mehmet ;
Lonnies, Helena ;
Dackland, Asa-Lena ;
Christensson, Birger ;
Le Blanc, Katarina .
JOURNAL OF IMMUNOTHERAPY, 2009, 32 (07) :755-764
[40]   Mesenchymal Stem Cell Transplantation for Neurodegenerative Diseases [J].
Torrente, Yvan ;
Polli, Elio .
CELL TRANSPLANTATION, 2008, 17 (10-11) :1103-1113